Abstract Nonsteroidal anti-inflammatory drugs (NSAIDs), such as cyclooxygenase (Cox)-1/2 inhibitor, have emerged as potent antipyretics and analgesics. However, few herbs with Cox-1/2 inhibitory activity are commonly used for heat-clearing in China. Although these are known to have antipyretic activity, there is a lack of molecular data supporting their activity. Using the traditional Chinese medicine herb honeysuckle (Hon) as an example, we explored key antipyretic active compounds and their mechanisms of action by assessing their metabolites and metabolomics. Mitogen-activated protein kinase (MAPK) 3 and protein kinase B (AKT) 1 were suggested as key targets regulated primarily by chlorogenic acid (CA) and swertiamarin (SWE). CA and SWE synergistically inhibited the production of interleukin (IL)-1 and IL-6, alleviated generation of prostaglandin E2, and played an antipyretic role equivalent to honeysuckle extract at the same dose contents within 3 h. Collectively, these findings indicated that lipopolysaccharide-induced fever can be countered by CA with SWE synergistically, allowing the substitution of a crude extract of complex composition with active compounds. Our findings demonstrated that, unlike the traditional NSAIDs, the Hon extract showed a remote and indirect mechanism for alleviating fever that depended on the phosphatidylinositol-3-kinase–AKT and MAPK pathways by regulating the principal mediator of inflammation. Keywords: metabolites, metabolomics, chlorogenic acid, swertiamarin, antipyretic, anti-inflammatory 1. Introduction Starting with aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), which target cyclooxygenase (COX)-1/2, have emerged as potent antipyretics and analgesics [[34]1]. However, almost no heat-clearing herbal medicines containing COX-1/2 inhibitors based on traditional Chinese medicine are being used for alleviating fever. One of the few examples of plants that are being used is honeysuckle (Hon), which refers to the flower buds of Lonicera japonica Thunb., possessing as it does potential anti-pyretic and anti-inflammatory activities, and which is widely used clinically after extraction [[35]2]. So far, more than 140 phytoconstituents have been identified from honeysuckle extracts. In addition to essential oils, an abundance of flavones, organic acids, iridoids, and triterpenoid saponins have also been found [[36]3]. However, the key component responsible for its antipyretic activity and its corresponding target remain unknown. Therefore, it is important to investigate the complex mechanism behind antipyretic activity exerted by these active compounds, as this will provide the knowledge required to precisely tailor therapies for various conditions, such as exopathogenic diseases, sores, carbuncles, and some infectious diseases. Natural products (NPs) remain the most prolific source of inspiration for the development of drugs [[37]4]. The novel modes of action exhibited by NPs have always made them a subject of great interest in medicine [[38]5]. With the exploration of NPs has become more common, increased access to biological and chemical data, and the development of data analysis algorithms, and integration of computational methods in NP drug discovery pipelines may be expected to increase significantly [[39]6]. Data pre-processing using convolutional neural networks reportedly performed better in peak alignment and identification from liquid chromatography–mass spectrometry (LC–MS), compound identification and quantification, and integration and interpretation of multi-omics data [[40]7]. Considering the complex and elusive nature of botanical products and their metabolism in the human body, metabolomic data generated for herbal drugs are large compared to those for single compounds. Combining information from different sources, that is, chemical, biochemical, biological, and in silico, with advanced computer algorithms and effectively handling big data can open new possibilities for NP research [[41]8]. Unfortunately, the integration of multi-omics data—those for the structures/components and for their targets—remains a challenge. Here, we used honeysuckle as a model herb and its extract to screen the key bioactive ingredients and potential protein targets in order to explore the antipyretic mechanism based on metabolites and metabolomic data. LC–MS coupled with molecular networking (MN) was adopted to analyze the prototype and metabolites in the blood and build a chemomic profiled network consisting of precursor ions. Virtual docking and annotation enrichment analyses were used to identify their structures and potential targets. Concurrently, a metabonomic assay was employed to detect the major reversal changes that were regulated by honeysuckle extractive preparation (HEP) administration in a lipopolysaccharide (LPS)-induced rat fever model. The interpretation of integrated data revealed chlorogenic acid (CA) and swertiamarin (SWE) as key compounds acting on both the phosphatidyl-inositol-3-kinase-protein kinase B (PI3K–AKT) and p38 mitogen-activated protein kinase (MAPK) pathways that are associated with fever. 2. Results 2.1. Global Metabolic Profiling Coupled with MN Identifies the Key Metabolites Global metabolite profiling based on negative and positive ion modes was performed to identify key metabolites in plasma derived from HEP, a honeysuckle oral liquid freeze-dried powder. The MS data of different groups were integrated into the Global Natural Product Social Molecular Networking (GNPS) platform. As shown in [42]Figure 1A, the MN map contained 1371 precursor ions, including 297 clusters (node ≥ 2) and 313 single nodes. Interestingly, compared with the overlapped metabolite distribution in HEP- and HEP-treated plasma ([43]Figure 1B), a total of eight main prototype components (P1-8) showed a significant difference in dysregulated metabolites. Based on the exact mass measurements and fragmentation patterns confirmed from references, as